This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Smith, T. J. Articles by Somerfield, M. R. Search for Related Content PubMed PubMed Citation Articles by Smith, T. J. Articles by Somerfield, M. R. Social Bookmarking                            What's this?

American Society of Clinical Oncology 1998 Update of Recommended Breast Cancer Surveillance Guidelines

From the American Society of Clinical Oncology.

Address reprint requests to American Society of Clinical Oncology, Health Services Research, 225 Reinekers Lane, Suite 650, Alexandria, VA 22314; email padbergj{at}asco.org

ABSTRACT

OBJECTIVE: To determine an effective, evidence-based, postoperative surveillance strategy for the detection and treatment of recurrent breast cancer. Tests are recommended only if they have an impact on the outcomes specified by American Society of Clinical Oncology (ASCO) for clinical practice guidelines.

POTENTIAL INTERVENTION: All tests described in the literature for postoperative monitoring were considered. In addition, the data were critically evaluated to determine the optimal frequency of monitoring.

OUTCOME: Outcomes of interest include overall and disease-free survival, quality of life, toxicity reduction, and secondarily cost-effectiveness.

EVIDENCE: A search was performed to determine all relevant articles published over the past 20 years on the efficacy of surveillance testing for breast cancer recurrence. These publications comprised both retrospective and prospective studies.

VALUES: Levels of evidence and guideline grades were rated by a standard process. More weight was given to studies that tested a hypothesis directly relating testing to one of the primary outcomes in a randomized design.

BENEFITS, HARMS, AND COSTS: The possible consequences of false-positive and -negative tests were considered in evaluating a preference for one of two tests providing similar information. Cost alone was not a determining factor.

RECOMMENDATIONS: The attached guidelines and text summarize the updated recommendations of the ASCO breast cancer expert panel. Data are sufficient to recommend monthly breast self-examination, annual mammography of the preserved and contralateral breast, and a careful history and physical examination every 3 to 6 months for 3 years, then every 6 to 12 months for 2 years, then annually. Data are not sufficient to recommend routine bone scans, chest radiographs, hematologic blood counts, tumor markers (carcinoembryonic antigen, cancer antigen [CA] 15-5, and CA 27.29), liver ultrasonograms, or computed tomography scans.

VALIDATION: The recommendations of the breast cancer expert panel were evaluated and supported by the ASCO Health Services Research Committee reviewers and the ASCO Board of Directors.

SPONSOR: American Society of Clinical Oncology.

NOTES

*Adopted on November 13, 1998, by the American Society of Clinical Oncology.

ASCO sincerely appreciates the contributions of the following members of the ASCO Breast Cancer Surveillance Expert Panel: Martha Bluming, Laura Esserman, Francine Halberg, Alexander Hantel, and Alexander Kennedy.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. M. Lee, D. Georgian-Smith, G. S. Gazelle, E. F. Halpern, E. A. Rafferty, R. H. Moore, E. D. Yeh, H. A. D'Alessandro, R. A. Hitt, and D. B. Kopans Detecting Nonpalpable Recurrent Breast Cancer: The Role of Routine Mammographic Screening of Transverse Rectus Abdominis Myocutaneous Flap Reconstructions Radiology, August 1, 2008; 248(2): 398 - 405. [Abstract] [Full Text] [PDF]

				H. Buyukhatipoglu, A. Sevinc, Y. Pehlivan, and C. Camci Is Prophylactic Cranial Irradiation a Possible Option for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer? J. Clin. Oncol., April 1, 2007; 25(10): 1292 - 1292. [Full Text] [PDF]

				N. L. Keating, M. B. Landrum, E. Guadagnoli, E. P. Winer, and J. Z. Ayanian Surveillance Testing Among Survivors of Early-Stage Breast Cancer J. Clin. Oncol., March 20, 2007; 25(9): 1074 - 1081. [Abstract] [Full Text] [PDF]

				N. L. Liberato, M. Marchetti, and G. Barosi Cost Effectiveness of Adjuvant Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer J. Clin. Oncol., February 20, 2007; 25(6): 625 - 633. [Abstract] [Full Text] [PDF]

				C. C. Earle Failing to Plan Is Planning to Fail: Improving the Quality of Care With Survivorship Care Plans J. Clin. Oncol., November 10, 2006; 24(32): 5112 - 5116. [Abstract] [Full Text] [PDF]

				E. Grunfeld Looking Beyond Survival: How Are We Looking at Survivorship? J. Clin. Oncol., November 10, 2006; 24(32): 5166 - 5169. [Abstract] [Full Text] [PDF]

				V. G. Vogel Identifying and Screening Patients at Risk of Second Cancers Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2027 - 2032. [Abstract] [Full Text] [PDF]

				F. Vigna-Taglianti, P. Vineis, A. Liberati, and F. Faggiano Quality of systematic reviews used in guidelines for oncology practice Ann. Onc., April 1, 2006; 17(4): 691 - 701. [Abstract] [Full Text] [PDF]

				E. Grunfeld, M. N. Levine, J. A. Julian, D. Coyle, B. Szechtman, D. Mirsky, S. Verma, S. Dent, C. Sawka, K. I. Pritchard, et al. Randomized Trial of Long-Term Follow-Up for Early-Stage Breast Cancer: A Comparison of Family Physician Versus Specialist Care J. Clin. Oncol., February 20, 2006; 24(6): 848 - 855. [Abstract] [Full Text] [PDF]

				J. L. Khatcheressian and T. J. Smith Randomized Trial of Long-Term Follow-Up for Early-Stage Breast Cancer: A Comparison of Family Physician Versus Specialist Care J. Clin. Oncol., February 20, 2006; 24(6): 835 - 837. [Full Text] [PDF]

				J. S. Mandelblatt, W. F. Lawrence, J. Cullen, A. L. Stanton, J. L. Krupnick, L. Kwan, and P. A. Ganz Patterns of Care in Early-Stage Breast Cancer Survivors in the First Year After Cessation of Active Treatment J. Clin. Oncol., January 1, 2006; 24(1): 77 - 84. [Abstract] [Full Text] [PDF]

				N. L. Keating, M. B. Landrum, E. Guadagnoli, E. P. Winer, and J. Z. Ayanian Factors Related to Underuse of Surveillance Mammography Among Breast Cancer Survivors J. Clin. Oncol., January 1, 2006; 24(1): 85 - 94. [Abstract] [Full Text] [PDF]

				T. J. Smith The American Society of Clinical Oncology Recommended Breast Cancer Surveillance Guidelines Can Be Done in a Routine Office Visit J. Clin. Oncol., September 20, 2005; 23(27): 6807 - 6807. [Full Text] [PDF]

				E. Even-Sapir Imaging of Malignant Bone Involvement by Morphologic, Scintigraphic, and Hybrid Modalities J. Nucl. Med., August 1, 2005; 46(8): 1356 - 1367. [Abstract] [Full Text] [PDF]

				N. L. Keating, M. B. Landrum, E. Meara, P. A. Ganz, and E. Guadagnoli Do Increases in the Market Share of Managed Care Influence Quality of Cancer Care in the Fee-For-Service Sector? J Natl Cancer Inst, February 16, 2005; 97(4): 257 - 264. [Abstract] [Full Text] [PDF]

				F. Puglisi, A. Follador, A. M. Minisini, G. G. Cardellino, S. Russo, C. Andreetta, S. Di Terlizzi, and A. Piga Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications Ann. Onc., February 1, 2005; 16(2): 263 - 266. [Abstract] [Full Text] [PDF]

				T. Hamaoka, J. E. Madewell, D. A. Podoloff, G. N. Hortobagyi, and N. T. Ueno Bone Imaging in Metastatic Breast Cancer J. Clin. Oncol., July 15, 2004; 22(14): 2942 - 2953. [Abstract] [Full Text] [PDF]

				N Hiramanek Breast cancer recurrence: follow up after treatment for primary breast cancer Postgrad. Med. J., March 1, 2004; 80(941): 172 - 176. [Abstract] [Full Text] [PDF]

				C. E. Holmes and H. B. Muss Diagnosis and Treatment of Breast Cancer in the Elderly CA Cancer J Clin, July 1, 2003; 53(4): 227 - 244. [Abstract] [Full Text]

				H. Kattlove and R. J. Winn Ongoing Care of Patients After Primary Treatment for Their Cancer CA Cancer J Clin, May 1, 2003; 53(3): 172 - 196. [Abstract] [Full Text] [PDF]

				C. L. Loprinzi, D. Hayes, and T. Smith Doc, Shouldn't We Be Getting Some Tests? J. Clin. Oncol., May 1, 2003; 21(90090): 108s - 111. [Full Text] [PDF]

				G. M. Yousef, A. Scorilas, L. G. Kyriakopoulou, L. Rendl, M. Diamandis, R. Ponzone, N. Biglia, M. Giai, R. Roagna, P. Sismondi, et al. Human Kallikrein Gene 5 (KLK5) Expression by Quantitative PCR: An Independent Indicator of Poor Prognosis in Breast Cancer Clin. Chem., August 1, 2002; 48(8): 1241 - 1250. [Abstract] [Full Text] [PDF]

				Y. Nieto, S. Nawaz, R. B. Jones, E. J. Shpall, P. J. Cagnoni, P. A. McSweeney, A. Baron, C. Razook, S. Matthes, and S. I. Bearman Prognostic Model for Relapse After High-Dose Chemotherapy With Autologous Stem-Cell Transplantation for Stage IV Oligometastatic Breast Cancer J. Clin. Oncol., February 1, 2002; 20(3): 707 - 718. [Abstract] [Full Text] [PDF]

				P. S. Wellman, E. P. Dalton, D. Krag, K. A. Kern, and R. D. Howe Tactile Imaging of Breast Masses: First Clinical Report Arch Surg, February 1, 2001; 136(2): 204 - 208. [Abstract] [Full Text] [PDF]

				E. A. Chen, G. A. Carlson, B. F. Coughlin, W. P. Reed Jr, J. L. Garb, and J. L. Frank Routine Chest Roentgenography Is Unnecessary in the Work-Up of Stage I and II Breast Cancer J. Clin. Oncol., October 20, 2000; 18(20): 3503 - 3506. [Abstract] [Full Text] [PDF]

				C. L. Loprinzi, D. Hayes, and T. Smith Doc, Shouldn't We Be Getting Some Tests? J. Clin. Oncol., June 11, 2000; 18(11): 2345 - 2348. [Full Text] [PDF]

				A. C. Wolff and N. E. Davidson Primary Systemic Therapy in Operable Breast Cancer J. Clin. Oncol., April 7, 2000; 18(7): 1558 - 1569. [Abstract] [Full Text] [PDF]

				Guidelines for Surveillance After Breast Cancer Journal Watch Women's Health, April 1, 1999; 1999(401): 7 - 7. [Full Text]

				Guidelines for Surveillance After Breast Cancer Journal Watch (General), March 23, 1999; 1999(323): 2 - 2. [Full Text]